Overview: What Is Cerebral?
Cerebral is a US-based telehealth platform launched in 2020 that combines online therapy with psychiatric medication management. Unlike pure therapy services such as BetterHelp, Cerebral employs licensed therapists alongside prescribers (NPs, PAs, and physicians) who can write prescriptions for non-controlled mental health medications. The company grew explosively during the pandemic, raising over $300M and reaching a $4.8B valuation, then collapsed in scrutiny when its prescribing practices and data sharing came under federal investigation.
Cerebral's value proposition is real: for adults with anxiety, depression, insomnia, or non-stimulant ADHD, getting a prescriber and a therapist on the same platform — often with insurance covering most of the cost — solves a coordination problem that traditional mental healthcare struggles with. But the company's recent history makes it impossible to recommend Cerebral without a long list of caveats, and we cover them honestly below.
The $7M FTC Settlement You Need to Know About
In April 2024, Cerebral agreed to a $7 million settlement with the Federal Trade Commission over allegations that it disclosed sensitive consumer health data — including mental health diagnoses and medications — to third-party advertisers including Facebook, Google, and TikTok without obtaining user consent. The FTC also alleged Cerebral used dark patterns to make cancellation difficult, charged users without authorization, and failed to honor cancellation requests.
This is the largest privacy-related FTC action ever brought against a mental health company. As part of the settlement, Cerebral is permanently banned from sharing health information with third parties for advertising purposes and was required to delete improperly shared data. The company has implemented new privacy controls, but the breach of trust is real, and any HIPAA-conscious user should weigh this seriously before signing up. Cerebral was also previously investigated by the DEA over its now-discontinued prescribing of controlled stimulants for ADHD.
Pricing Breakdown
| Plan | Price/Month | Details |
|---|---|---|
| Therapy Only | $60–$99 | Per-session billing available at $175/session, Monthly plan for regular therapy |
| Medication + Prescriber | $99–$199 | Includes prescriber consultations, Medication management |
| Therapy + Medication | $365 | Comprehensive care plan, Therapy sessions + prescriber access, Medication management |
Cerebral's headline strength is its insurance coverage. Where BetterHelp is fully cash-pay at $260-$400/month, Cerebral accepts most major US payers and many users pay only a $20-$30 copay per visit. For users with commercial insurance, that's the cheapest path to ongoing therapy plus medication management on the market. Out of pocket, however, the $365/month combined plan is comparable to BetterHelp without the same therapist depth.
Key Features
- AI-assisted therapist and prescriber matching
- Online psychiatry with medication prescriptions (non-controlled substances)
- Therapy sessions with licensed counselors
- Medication tracking and refill management
- Progress measurement and outcome tracking
- Insurance accepted (major US payers)
- Care team model (therapist + prescriber together)
The clinical model uses a "care team" approach — your therapist and prescriber are nominally collaborating on a single plan, with shared notes and aligned medication and therapy goals. In practice, the integration is uneven: clinician turnover is high, and reassignments can break continuity. Cerebral cannot prescribe stimulants (Adderall, Vyvanse) for ADHD or benzodiazepines (Xanax, Ativan) for anxiety, both of which were previously offered and pulled after DEA scrutiny.
The AI Component
Cerebral's AI is concentrated in intake and matching. The intake assessment uses NLP to triage symptoms into a recommended care pathway — therapy only, medication only, or combined — and routes users to clinicians whose specialties and licenses match. Outcome tracking dashboards use trend analysis to flag worsening PHQ-9 or GAD-7 scores between visits. There is no AI therapy chatbot in the Wysa or Woebot sense: all care delivery is from licensed humans.
We could find no peer-reviewed RCTs validating Cerebral's matching algorithm or its outcome-tracking AI. The company has published satisfaction metrics (94% psychiatry, 90% therapy) but these are self-reported, not independently audited.
Pros and Cons
Strengths
- ✓ Combined therapy + medication on a single platform
- ✓ Insurance accepted by major US payers (often $20-$30 copay)
- ✓ Care-team model coordinates therapist and prescriber
- ✓ No referral required for psychiatric prescribing
- ✓ 4.6/5 App Store, 4.4/5 Trustpilot — better than most telehealth peers
Weaknesses
- ✗ FTC investigation settled for $7M (2024) — shared user health data with Facebook/advertisers without consent
- ✗ High provider turnover leading to inconsistent care
- ✗ Cannot prescribe stimulants (ADHD) or benzodiazepines
- ✗ Billing disputes and difficult cancellations
- ✗ Requires payment before first appointment — frustrating for users who don't fit with provider
- ✗ Out-of-pocket costs expensive without insurance
- ✗ Regulatory scrutiny and reputational damage from FTC settlement
Cerebral vs BetterHelp
BetterHelp is therapy-only, cash-pay, and has a much larger therapist network (34,000+) but no medication management. Cerebral is smaller, accepts insurance, and offers therapy plus prescribing in one place. If you need medication and therapy together and you have commercial insurance, Cerebral is almost certainly cheaper. If you only need therapy and you want the deepest therapist bench (or you live outside the US), BetterHelp wins. Read our full BetterHelp vs Cerebral comparison.
Who Should Use Cerebral
Cerebral is best for US adults with commercial insurance who need both medication management and therapy for moderate anxiety, depression, or insomnia, and who are comfortable with the company's privacy track record after the FTC settlement. It is appropriate for users who have already tried first-line SSRIs and want continuity of care across therapy and prescribing.
Cerebral is not appropriate for crisis intervention (call 988), severe psychiatric conditions, ADHD requiring stimulants, anxiety requiring benzodiazepines, eating disorders, substance use disorders, or any user who is not comfortable with the company's documented data-sharing history. International users are not served.
Verdict
Cerebral solves a real problem — coordinated, insurance-covered telepsychiatry plus therapy — but it does so under the shadow of a $7M FTC settlement and ongoing reputational damage. For US users with insurance who need both medication and therapy and who prefer one-stop care, Cerebral can be cost-effective. For privacy-sensitive users, users outside the US, or anyone needing controlled substances, look elsewhere. We cautiously recommend Cerebral with a strong warning about privacy history and cancellation friction.
↗ affiliate link — $12 per signup